Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TNXP · against 99 other Healthcare companies of similar size
Ranked #30 of 100 · scores higher than 71% of peers · safety percentile 59
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)12 peers with a safety percentile of 50–59, including TNXP · Click a bar to see the companies
A mix: stronger debt / equity and current ratio, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | TNXP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 87 reported | 0.01× | 0.23× | 98% | 33% | |
| BetaLower is better · 96 reported | 1.75 | 0.71 | 14% | 33% | |
| Current ratioHigher is better · 101 reported | 6.61× | 2.38× | 81% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 165M USD | 99 | 50 | |
| 2 | 8.4B JPY (≈$57M) | 98 | ||
| 3 | 5.7B TWD (≈$177M) | 97 | 65 | |
| 4 | 1.1B NOK (≈$105M) | 96 | 58 | |
| 5 | 111M USD | 96 | ||
| 26 | 540M ILS (≈$146M) | 65 | 49 | |
| 27 | 244.2B KRW (≈$176M) | 63 | 72 | |
| 28 | 217M AUD (≈$143M) | 63 | 43 | |
| 29 | 720M HKD (≈$92M) | 63 | 62 | |
| 30 | 89M USD | 59 | 31 | |
| 31 | 100M USD | 58 | 37 | |
| 32 | 171.0B KRW (≈$123M) | 58 | 41 | |
| 33 | 2.9B TWD (≈$90M) | 56 | 58 | |
| 34 | 834M HKD (≈$107M) | 55 | 57 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score